FOXO4‑DRI 10 mg
CAS Number: 1794633‑68‑8
Sequence: Ac‑RKKRRQRRR‑YARLQKGN‑NH₂
Molecular Formula: C₉₀H₁₆₀N₃₄O₁₈
Molecular Weight: ~1980.4 g/mol
Content: 10 mg (lyophilised)
Key Features
Purity: ≥ 98% (HPLC‑verified)
Form: Freeze‑dried (lyophilised) powder
Documentation: Certificate of Analysis (COA) provided for each batch
Origin: UK‑stocked for fast, tracked Royal Mail delivery
Storage: –20 °C in a temperature‑controlled facility until dispatch
Molecular Information
FOXO4‑DRI is a synthetic peptide inhibitor derived from the FOXO4 interaction domain, supplied in high‑purity, lyophilised form for controlled laboratory studies, analytical workflows, and in‑vitro research applications.
Its sequence incorporates a cell‑penetrating domain to support mechanistic investigations into protein–protein interactions and senescence‑associated pathways.
Storage & Stability
Long‑term: Store at –20 °C in a dry, sealed container
Short‑term: Maintain under standard laboratory cold‑chain conditions
Protect from moisture and avoid repeated freeze–thaw cycles.
Intended Use
For laboratory research only.
Not for human or animal consumption.
Not approved for diagnostic, therapeutic, or medical applications.
Handle using standard laboratory safety procedures.
Why Choose FOXO4‑DRI 10 mg?
- High‑purity peptide suitable for precision research
- COA included for batch verification and documentation
- Lyophilised format ensures stability during storage and shipping
- UK‑stocked for rapid and reliable delivery
Search‑Optimised Keywords
FOXO4‑DRI, FOXO4‑DRI peptide, FOXO4‑DRI 10 mg, FOXO4 inhibitor peptide, FOXO4‑derived inhibitor, synthetic research peptide UK, lyophilised peptide powder, high‑purity FOXO4‑DRI, laboratory‑grade peptide.
| Weight | 100 g |
|---|---|
| Dimensions | 1 × 1 × 3 cm |
